Bengaluru, 19 May, 2025: Fortis Hospitals, Bengaluru has signed a Memorandum of Understanding with Teleflex Incorporated, a leading global provider of medical technologies to create UroLift Center of Education for South Asia in India.
The UroLiftTM System uses a minimally invasive approach to treating Benign Prostatic Hyperplasia (BPH). BPH is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life. The UroLiftTM System is the only leading BPH procedure that does not require heating, cutting, removal, or destruction of prostate tissue. The UroLiftTM System provides rapid symptom relief and preserves sexual function. Typically, no catheter is required after the treatment.
Dr. Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare Limited remarked, “The healthcare landscape continues to evolve, and more minimally invasive therapies continue to emerge. At Fortis, we always strive to offer superior technologies to our patients. This educational initiative in association with Teleflex is another testament to our commitment to quality patient care.”
“At Teleflex, we believe that education is the foundation of progress in healthcare. Our collaboration with Fortis Hospitals will empower medical professionals with advanced knowledge and hands-on training, ultimately improving patient care,” said Arun Kaushik, Managing Director, South Asia, Teleflex.
Dr. Mohan Keshavamurthy, Principal Director – Renal Sciences, Fortis Hospitals, Bengaluru said, “Through this collaboration, we are committed to helping Urologists acquire requisite skill to optimize individualized treatment solutions such as UROLIFT for patients requiring Endoscopic surgical solutions for BPH and enhancing outcomes thereof. The program is designed to provide a comprehensive training program to Urologists to ensure careful selection and safe delivery of UROLIFT System to patients in their practice.”